20 Investor Report Industrial Hemp Sector New Zealand ’ s New Export Opportunity 2020
3 . HEMP HEALTH MARKETS - COUNTRY COMPARISONS
HEMP CANNABINOIDS ( CBD ) AND THE ENDOCANNABINOID SYSTEM
The endo-cannabinoid system ( ECS ) is responsible for managing the complex parts of a human : A vast range of physiological processes including mood , memory , pain-sensation , and appetite . It monitors irregularities in different systems and helps communicate corrective action to restore homeostasis . Body temperature is a simple example , and the immune system is a more complex one . Research has proved that humans create their own endocannabinoids , such as dopamine and serotonin , inside the body . These are not stored , but formed as and when the body needs them .
Cannabidiol ( CBD ) was discovered in 1940 and THC in 1963 . Professor Raphael Mechoulam has led a major output of Israeli research studies in the 1970 ’ s , 80 ’ s and 90 ’ s which has identified more cannabinoids , along with an understanding of the endocannabinoid system ( discovered in the 1990 ’ s ) and its relationship to cannabis-sourced ( phyto ) cannabinoids . Through the continuous research findings and influence of Mechoulam ’ s work , Israel has become a global centre of research and commercial development . ( 3 , 4 )
Further research studies relating to CBD and THC have shown that while these cannabinoids are chemically similar , they have almost opposite effects on the human body in the way they interact with the body ’ s receptors .
Research studies appear to show that CBD can help with conditions such as :
• Seizures , inflammation and pain
• Psychosis or mental disorders , depression and anxiety
• Nausea and inflammatory bowel disease
• Migraines
THC research studies suggest that THC can help with
• Pain and nausea